M&A · Healthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Blackstone Inc. to acquire Hologic Inc
Announced Oct 21, 2025 · Closed Apr 7, 2026
Deal value$16.90BEV $17.68B
Premium46.0%To unaffected price
EV / Adj. EBITDA13.7x4.4x EV / Revenue
ConsiderationAll cash$76.00 per share
Transaction
- Acquirer
- Blackstone Inc. (BX)
- Target
- Hologic Inc (HOLX)
- Buyer type
- Private equity
- Offer price per share
- $76.00
- Enterprise value
- $17.68B
- Status
- Closed Apr 7, 2026
Deal protections
- Break fee (target pays)
- $540M · 3.2%
- Reverse fee (buyer pays)
- $900M · 5.3%
- Go-shop
- Go-shop
- Financing
- No financing condition
Advisors
- To the acquirer
- Citigroup
- To the target
- Goldman Sachs
Sector context · Healthcare
- Comparable deals
- 93 in the prior 24 months
- Premium
- 46.0% vs. 60.5% sector median
- EV / Adj. EBITDA
- 13.7x vs. 15.9x sector median
- Break fee
- 3.2% vs. 3.3% sector median
Timeline
- AnnouncedOct 21, 2025
- Proxy filedDec 12, 2025
- Definitive proxyDec 23, 2025
- Shareholder voteFeb 5, 2026
- ClosedApr 7, 2026
Valuation · fairness opinions
Discounted cash flow$66.67$99.09
Future share price$56.00$77.00
Premiums paid$63.00$73.00
Offer $76.00
Implied value per Hologic Inc share by analysis, from Goldman Sachs · DCF discount rate 8.5%–10.5%.